Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
[18F]F-Ara-G
DRUG
2 trials
Sponsors
University of California, San Francisco
, CellSight Technologies, Inc.
Conditions
Graft Versus Host Disease
Non-small Cell Lung Cancer
Phase 1
Detection of Graft Versus Host Disease With [18F]F-AraG
Completed
NCT03367962
CellSight Technologies, Inc.
Graft Versus Host Disease
Start: 2018-05-15
End: 2023-10-21
Updated: 2025-12-08
Phase 2
T-Cell PET Imaging With [18F]F-AraG in Lung Cancer
Withdrawn
NCT03311672
University of California, San Francisco
Non-small Cell Lung Cancer
Start: 2017-11-26
End: 2019-10-15
Updated: 2019-10-21